Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Dolphin Intertrade Corporation
WARNING LETTER
•Dolphin Intertrade Corporation•May 17, 2013

Dolphin Intertrade Corporation – FDA Warning Letter, May 17, 2013

Record Details

The FDA issued a Warning Letter to Dolphin Intertrade Corporation following an inspection from May 10-17, 2013, and review of their website, www.jadera.net. The FDA determined that Jadera and Xiyouji Qingzhi, marketed as dietary supplements, are unapproved new drugs and misbranded drugs.

Laboratory analyses confirmed both products contain undeclared sibutramine, an active pharmaceutical ingredient in Meridia, which was withdrawn from the U.S. market in 2010 due to increased risks of heart attack and stroke. Sibutramine is excluded from the definition of a dietary supplement because it was authorized for investigation as a new drug before being marketed as a dietary supplement or food.

Jadera and Xiyouji Qingzhi are considered drugs due to their intended uses, such as "Lose Weight Effectively" and "Curb Your Appetite," and are new drugs as they are not generally recognized as safe and effective. Their distribution without FDA-approved applications violates sections 301(d) and 505(a) of the Act.

Furthermore, the products are misbranded under section 502(f)(1) for lacking adequate directions for use, as sibutramine requires professional supervision and was withdrawn due to safety risks. They are also misbranded under section 502(a) for false and misleading safety statements and failure to disclose material facts, and under section 5

Company
Dolphin Intertrade Corporation
Inspection date
May 17, 2013
Product type
Drugs
Office
Florida District Office
People
  • Emma R. Singleton (District Director)
  • Graziano Iezzi
View Company Profile

ID · 156c93bd-94b0-469e-bfd5-26dba9511b3d

Violation Codes10
21 U.S.C. 34321 U.S.C. 331(a)21.U.S.C. 355(a)21 U.S.C. 35221 U.S.C. 35321 U.S.C. 321(ff)(3)(B)(ii)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)21 U.S.C. 331(d)21 U.S.C. 352(f)(1)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dolphin Intertrade Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.